MK-0472

· Merck Sharp & Dohme LLC

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MK-0472, covering 2026-03-13 to 2026-03-13. Get the full timeline:

Most recent: Clinical Trial Update: Study of MK-0472 in Participants With Advanced/Metastatic Solid Tumors (MK-0472-001) [Phase 1]